246 related articles for article (PubMed ID: 27318956)
1. PSMA Theranostics Using PET and Subsequent Radioguided Surgery in Recurrent Prostate Cancer.
Maurer T; Schwamborn K; Schottelius M; Wester HJ; Schwaiger M; Gschwend JE; Eiber M
Clin Genitourin Cancer; 2016 Oct; 14(5):e549-e552. PubMed ID: 27318956
[No Abstract] [Full Text] [Related]
2. [PSMA-radioguided surgery in localised recurrent prostate cancer].
Horn T; Rauscher I; Eiber M; Gschwend JE; Maurer T
Urologe A; 2017 Nov; 56(11):1417-1423. PubMed ID: 29022058
[TBL] [Abstract][Full Text] [Related]
3. Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer.
Horn T; Krönke M; Rauscher I; Haller B; Robu S; Wester HJ; Schottelius M; van Leeuwen FWB; van der Poel HG; Heck M; Gschwend JE; Weber W; Eiber M; Maurer T
Eur Urol; 2019 Oct; 76(4):517-523. PubMed ID: 30987843
[TBL] [Abstract][Full Text] [Related]
4. [The role of PSMA PET-CT in patients with metastatic prostate cancer].
von Hardenberg J; Büsing KA; Nuhn P; Ritter M
Urologe A; 2017 Nov; 56(11):1410-1416. PubMed ID: 28980045
[TBL] [Abstract][Full Text] [Related]
5. Metastases-yield and Prostate-specific Antigen Kinetics Following Salvage Lymph Node Dissection for Prostate Cancer: A Comparison Between Conventional Surgical Approach and Prostate-specific Membrane Antigen-radioguided Surgery.
Knipper S; Tilki D; Mansholt J; Berliner C; Bernreuther C; Steuber T; Maurer T; Graefen M
Eur Urol Focus; 2019 Jan; 5(1):50-53. PubMed ID: 30292421
[TBL] [Abstract][Full Text] [Related]
6. Hybrid positron emission tomography-magnetic resonance imaging with gallium 68 prostate-specific membrane antigen tracer: a next step for imaging of recurrent prostate cancer-preliminary results.
Roethke MC; Kuru TH; Afshar-Oromieh A; Schlemmer HP; Hadaschik BA; Fenchel M
Eur Urol; 2013 Nov; 64(5):862-4. PubMed ID: 23954084
[No Abstract] [Full Text] [Related]
7. Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer.
Barrio M; Fendler WP; Czernin J; Herrmann K
Expert Rev Mol Diagn; 2016 Nov; 16(11):1177-1188. PubMed ID: 27679869
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy.
Henkenberens C; Oehus AK; Derlin T; Bengel F; Ross TL; Kuczyk MA; Janssen S; Christiansen H; von Klot CAJ
Strahlenther Onkol; 2020 Nov; 196(11):1006-1017. PubMed ID: 32399639
[TBL] [Abstract][Full Text] [Related]
9. Robot-assisted Prostate-specific Membrane Antigen-radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study.
de Barros HA; van Oosterom MN; Donswijk ML; Hendrikx JJMA; Vis AN; Maurer T; van Leeuwen FWB; van der Poel HG; van Leeuwen PJ
Eur Urol; 2022 Jul; 82(1):97-105. PubMed ID: 35339318
[TBL] [Abstract][Full Text] [Related]
10. Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists.
Shakespeare TP
Radiat Oncol; 2015 Nov; 10():233. PubMed ID: 26582424
[TBL] [Abstract][Full Text] [Related]
11. The role of PSMA PET scans in salvage therapy planning.
Goonewardene S; Alsheikh M
World J Urol; 2018 Mar; 36(3):503-504. PubMed ID: 29243112
[No Abstract] [Full Text] [Related]
12. Prostate-specific membrane antigen for prostate cancer theranostics: from imaging to targeted therapy.
Arsenault F; Beauregard JM; Pouliot F
Curr Opin Support Palliat Care; 2018 Sep; 12(3):359-365. PubMed ID: 29939893
[TBL] [Abstract][Full Text] [Related]
13. Image-Guided Surgery: Are We Getting the Most Out of Small-Molecule Prostate-Specific-Membrane-Antigen-Targeted Tracers?
Hensbergen AW; van Willigen DM; van Beurden F; van Leeuwen PJ; Buckle T; Schottelius M; Maurer T; Wester HJ; van Leeuwen FWB
Bioconjug Chem; 2020 Feb; 31(2):375-395. PubMed ID: 31855410
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic Database.
Bahler CD; Johnson MM; Davicioni E; Zhang J; Cheng L; Green MA; Koch MO
Urology; 2020 Oct; 144():117-122. PubMed ID: 32619596
[TBL] [Abstract][Full Text] [Related]
15. The theranostic target prostate-specific membrane antigen is expressed in medullary thyroid cancer.
Lodewijk L; Willems SM; Dreijerink KMA; de Keizer B; van Diest PJ; Schepers A; Morreau H; Bonenkamp HJ; Van Engen-van Grunsven IACH; Kruijff S; van Hemel BM; Links TP; Nieveen van Dijkum E; van Eeden S; Valk GD; Borel Rinkes IHM; Vriens MR
Hum Pathol; 2018 Nov; 81():245-254. PubMed ID: 30055186
[No Abstract] [Full Text] [Related]
16. The Role of Positron Emission Tomography With (68)Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy.
Rai BP; Baum RP; Patel A; Hughes R; Alonzi R; Lane T; Adshead J; Vasdev N
Urology; 2016 Sep; 95():11-5. PubMed ID: 26790588
[TBL] [Abstract][Full Text] [Related]
17. Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease.
Rhee H; Ng KL; Tse BW; Yeh MC; Russell PJ; Nelson C; Thomas P; Samaratunga H; Vela I; Gobe G; Wood S
Pathology; 2016 Oct; 48(6):613-6. PubMed ID: 27567227
[No Abstract] [Full Text] [Related]
18. Imaging Prostate Cancer: Clinical Utility of Prostate-Specific Membrane Antigen.
Kuppermann D; Calais J; Marks LS
J Urol; 2022 Apr; 207(4):769-778. PubMed ID: 35085002
[TBL] [Abstract][Full Text] [Related]
19. Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications.
Rowe SP; Gorin MA; Pomper MG
Annu Rev Med; 2019 Jan; 70():461-477. PubMed ID: 30691373
[TBL] [Abstract][Full Text] [Related]
20. [PSMA-based theranostics for prostate cancer : From imaging to treatment].
Ilhan H; la Fougère C; Krause BJ
Urologe A; 2020 May; 59(5):617-625. PubMed ID: 32377764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]